103 related articles for article (PubMed ID: 20032105)
1. Incidence of Wegener's granulomatosis in children.
Grisaru S; Yuen GW; Miettunen PM; Hamiwka LA
J Rheumatol; 2010 Feb; 37(2):440-2. PubMed ID: 20032105
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Wegener's granulomatosis in northern Norway.
Koldingsnes W; Nossent H
Arthritis Rheum; 2000 Nov; 43(11):2481-7. PubMed ID: 11083271
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.
Knight A; Ekbom A; Brandt L; Askling J
J Rheumatol; 2006 Oct; 33(10):2060-3. PubMed ID: 16960922
[TBL] [Abstract][Full Text] [Related]
4. Wegener's granulomatosis: epidemiological and clinical features in a South Australian study.
Hissaria P; Cai FZ; Ahern M; Smith M; Gillis D; Roberts-Thomson P
Intern Med J; 2008 Oct; 38(10):776-80. PubMed ID: 19143878
[TBL] [Abstract][Full Text] [Related]
5. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
Gibson A; Stamp LK; Chapman PT; O'Donnell JL
Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
[TBL] [Abstract][Full Text] [Related]
7. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient.
O'Donnell JL; Stevanovic VR; Frampton C; Stamp LK; Chapman PT
Intern Med J; 2007 Apr; 37(4):242-6. PubMed ID: 17388864
[TBL] [Abstract][Full Text] [Related]
8. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
[TBL] [Abstract][Full Text] [Related]
9. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
10. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
Faurschou M; Mellemkjaer L; Sorensen IJ; Svalgaard Thomsen B; Dreyer L; Baslund B
Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
12. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
13. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gutfleisch J; Peter HH; Raspe HH; Gross WL
Arthritis Rheum; 2002 Jun; 47(3):320-5. PubMed ID: 12115163
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
Ormerod AS; Cook MC
Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
[TBL] [Abstract][Full Text] [Related]
15. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
16. Wegener's granulomatosis: the relationship between ocular and systemic disease.
Harper SL; Letko E; Samson CM; Zafirakis P; Sangwan V; Nguyen Q; Uy H; Baltatzis S; Foster CS
J Rheumatol; 2001 May; 28(5):1025-32. PubMed ID: 11361183
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.
Mohammad AJ; Jacobsson LT; Mahr AD; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2007 Aug; 46(8):1329-37. PubMed ID: 17553910
[TBL] [Abstract][Full Text] [Related]
18. Wegener's granulomatosis in patients with rheumatoid arthritis.
Douglas G; Bird K; Flume P; Silver R; Bolster M
J Rheumatol; 2003 Sep; 30(9):2064-9. PubMed ID: 12966617
[TBL] [Abstract][Full Text] [Related]
19. Wegener's granulomatosis: managing more than inflammation.
Seo P
Curr Opin Rheumatol; 2008 Jan; 20(1):10-6. PubMed ID: 18281851
[TBL] [Abstract][Full Text] [Related]
20. Impaired health-related quality of life in patients treated for Wegener's granulomatosis.
Faurschou M; Sigaard L; Bjorner JB; Baslund B
J Rheumatol; 2010 Oct; 37(10):2081-5. PubMed ID: 20682665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
